| European Case Law Identifier: | ECLI:EP:BA:2013:T195509.20130612 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 12 June 2013 | ||||||||
| Case number: | T 1955/09 | ||||||||
| Application number: | 05769152.9 | ||||||||
| IPC class: | A61K 38/17 A61K 31/04 A61P 31/10 |
||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | D | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | Antimicrobial peptides derived from CAP18 | ||||||||
| Applicant name: | OctoPlus Sciences B.V. Academisch Ziekenhuis Leiden |
||||||||
| Opponent name: | - | ||||||||
| Board: | 3.3.04 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: |
|
||||||||
| Keywords: | Main request - Claim 1 - novelty (yes) | ||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t091955eu1.html
Date retrieved: 17 May 2021